413 filings
Page 2 of 21
8-K
stp cfppj7e3g926
10 Aug 23
Submission of Matters to a Vote of Security Holders
8:01am
DEFA14A
kzca8 my8snsw
25 Jul 23
Additional proxy soliciting materials
4:03pm
8-K
1j40 wnnou0
25 Jul 23
Other Events
4:02pm
8-K
kx2mogzvd5qwbhtdlq7
6 Jul 23
ENDRA Life Sciences Announces Adjournment of
5:25pm
DEFA14A
ag0j2w9vfocev
6 Jul 23
Additional proxy soliciting materials
5:25pm
ARS
i2ju3lmb
24 May 23
Annual report to shareholders
4:13pm
DEFA14A
cty6cwdtav0xqhw0q695
24 May 23
Additional proxy soliciting materials
4:04pm
4
w46t71 wh3
22 May 23
ENDRA Life Sciences / Michael Milos Thornton ownership change
7:30am
8-K
ur244zzqd 3mt0hgpg6o
15 May 23
ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update
12:00am
4
cnjrmg8303wfvhwwwa36
3 May 23
ENDRA Life Sciences / ANTHONY DIGIANDOMENICO ownership change
4:07pm
8-K
faabfmpfk mdk
2 May 23
ENDRA Life Sciences Announces Pricing of Upsized $4.5 Million Public Offering
4:16pm
424B5
4y10uxzhav6i5
28 Apr 23
Prospectus supplement for primary offering
4:51pm
S-1MEF
yh2kc rnu9dzyykpp7s
28 Apr 23
Registration of additional securities for an S-1
6:07am
EFFECT
kalyky6
28 Apr 23
Notice of effectiveness
12:15am
CORRESP
f6qmtp6s
24 Apr 23
Correspondence with SEC
12:00am
CORRESP
twtgjdv48jv5d n9ge3e
24 Apr 23
Correspondence with SEC
12:00am
8-K
843ylg2zh3v06o p3jq7
18 Apr 23
Recent Financial Results
9:09am